Gemifloxacin Mesylate
Mostrando 1-6 de 6 artigos, teses e dissertações.
-
1. Determination of Gemifloxacin in human plasma by high performance liquid chromatography using Ultra Violet detector and its application to a bioequivalence study
A liquid chromatography method was developed and validated for the determination of gemifloxacin in human plasma using chloramphenicol as internal standard to achieve lower quantification limit. Acetonitrile was used to precipitated and extracted analyte and internal standard from plasma by Protein Precipitation. Analysis was performed isocratically on C18 c
Braz. J. Pharm. Sci.. Publicado em: 08/04/2019
-
2. Gemifloxacin mesylate: UV spectrophotometric method for quantitative determination using experimental design for robustness
This study describes the validation of UV spectrophotometric method for quantitative determination of gemifloxacin mesylate (GFM) in tablets using methanol as solvent. The method was specific, linear, precise, exact and robust at 272 and 343 nm. The results confirmed that the method in both wavelengths is valid and useful to the routine quality control of GF
Química Nova. Publicado em: 2012
-
3. Mesilato de gemifloxacino : desenvolvimento e validação de métodos analíticos, teste de dissolução e estudo de estabilidade
A análise de fármacos é fundamental nas diversas fases do desenvolvimento farmacêutico, tais como em estudos de formulação, estabilidade e controle de qualidade do produto. O mesilato de gemifloxacino (MGF), liberado para uso clínico no Brasil em novembro de 2006 com o nome comercial de Factive®, é uma fluorquinolona indicada para o tratamento da ex
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 2012
-
4. Gemifloxacin Is Effective in Experimental Pneumococcal Meningitis
In a rabbit model of Streptococcus pneumoniae meningitis, 5 mg of gemifloxacin mesylate (SB-265805) per kg/h reduced the bacterial titers in cerebrospinal fluid (CSF) almost as rapidly as 10 mg of ceftriaxone per kg/h (Δlog CFU/ml/h ± standard deviation [SD], −0.25 ± 0.09 versus −0.38 ± 0.11; serum and CSF concentrations of gemifloxacin were 2.1 ± 1
American Society for Microbiology.
-
5. In Vitro Activity of Gemifloxacin (SB 265805) against Anaerobes
Gemifloxacin mesylate (SB 265805), a new fluoronaphthyridone, was tested against 359 recent clinical anaerobic isolates by the National Committee for Clinical Laboratory Standards reference agar dilution method with supplemented brucella blood agar and an inoculum of 105 CFU/spot. Comparative antimicrobials tested included trovafloxacin, levofloxacin, grepaf
American Society for Microbiology.
-
6. Multiple-Dose Pharmacokinetics and Tolerability of Gemifloxacin Administered Orally to Healthy Volunteers
Gemifloxacin mesylate (SB-265805-S, LB-20304a) is a potent, novel fluoroquinolone agent with a broad spectrum of antibacterial activity. The pharmacokinetics and tolerability of oral gemifloxacin were characterized in two parallel group studies in healthy male volunteers after doses of 160, 320, 480, and 640 mg once daily for 7 days. Multiple serum or plasma
American Society for Microbiology.